The global medical nutrition therapy (MNT) market size was estimated at USD 28.64 billion in 2025 and is predicted to increase from USD 30.91 billion in 2026 to approximately USD 61.38 billion by 2035, expanding at a CAGR of 7.92% from 2026 to 2035. The medical nutrition therapy (MNT) market is growing as MNT using personalized, client-driven, and evidence-based strategies has the strength to enhance population health, lower health disparities, and reduce health care expenses related to nutrition-associated health conditions.
Medical nutrition therapy (MNT) is a procedure of manage which uses nutrition education and behavioural counselling to avoid or manage a medical condition. Medical nutrition therapy supports the management of many different medical conditions including chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), conditions affecting the digestive system, such as celiac disease, Crohn’s disease, irritable bowel syndrome (IBS), and ulcerative colitis, diabetes (Type 1, Type 2, and gestational), and prediabetes, heart failure, high blood pressure. Medical nutrition therapy (MNT) is an evidence-based, modified nutrition therapy meant to help treat certain medical conditions.
AI is actively governing the market by transitioning it from a one-size-fits-all model to a hyper-personalized, data-driven system. By 2026, AI technologies, including machine learning (ML), computer vision, and natural language processing (NLP), will be deeply integrated into nutrition assessment, meal planning, and continuous monitoring, serving as a critical tool for registered dietitians (RDs) and patients alike.
Precision Nutrition & Personalization:
Precision nutrition evaluates one's DNA, microbiome, and metabolic response to particular foods or dietary patterns to control the most efficient eating plan. Targeted nutrition strategies aim to leverage human variability to design tailored dietary interventions to enhance health
Digital Health Integration:
Digital healthcare provides a massive range of possibilities and enhances the quality of patient care. Patients use apps for food logging, barcode scanning, and symptom tracking, facilitating better adherence to nutrition interventions.
Hybrid and Multi-Cloud Dominance:
Enteral nutrition with EPA and DHA may be advantageous in patients with head and neck or oesophageal tumors by enhancing parameters of nutritional and functional status throughout CRT.
| Table | Scope |
| Market Size in 2026 | USD 30.91 Billion |
| Projected Market Size in 2035 | USD 61.38 Billion |
| CAGR (2026 - 2035) | 7.92% |
| Leading Region | North America by 38% |
| Key Applications | Diabetes management, oncology nutrition, enteral nutrition, parenteral nutrition, critical care nutrition, renal nutrition, geriatric nutrition, gastrointestinal disorders |
| Primary End Users | Hospitals, home healthcare providers, long-term care facilities, specialty clinics, ambulatory care centers |
| Key Challenges | Reimbursement limitations, patient adherence issues, high treatment costs, regulatory complexity, shortage of clinical dietitians |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product Type, By Therapeutic Area, By Application, By Route of Administration, By Age Group, By Formulation, By Distribution Channel, By End User, By Region |
| Top Key Players | Abbott Laboratories, Nestlé Health Science, Fresenius Kabi, Danone Nutricia, Baxter International Inc. |
| Segment | Share 2025 (%) |
| Oral Nutritional Supplements (ONS) | 42% |
| Enteral Nutrition | 31% |
| Parenteral Nutrition | 16% |
| Specialized Nutritional Products | 11% |
The Oral Nutritional Supplements (ONS) Segment Led the Medical Nutrition Therapy (MNT) Market in 2025
The oral nutritional supplements (ONS) segment contributed the largest market share of 42% in 2025, as ONS offers a convenient and effective way to deliver the necessary nutrients. ONS has been demonstrated to significantly promote weight gain in undernourished elderly individuals. Oral nutrition supplements come in numerous different forms, like powders, liquids, shakes, bars, and more. Every type is unique in flavor, texture, and nutrients.
The enteral nutrition segment held a significant share of 31% in the market, as enteral nutrition over parenteral nutrition involves safety, efficiency, lowered challenges of infection, decreased expenses, prevention of gut atrophy, and preservation of the gut's barrier function. Enteral nutrition uses the gastrointestinal tract to supply nutrients. This is accomplished by feeding by mouth or through a feeding tube.
The parenteral nutrition segment held a significant share of 16% of the medical nutrition therapy (MNT) market, as parenteral nutrition (TPN) provides significant advantages, significantly by enabling nutritional services to be infused for 8 to 18 hours daily. Parenteral nutrition (PN) offers essential nutrients directly into the bloodstream, bypassing the gastrointestinal (GI) tract to sustain patients who cannot usually eat or absorb food.
The specialized nutritional products segment held a significant share of 11% of the market and is expected to grow at the fastest 9.42% CAGR during the forecast period, as specialized nutritional products provide targeted health advantages by addressing particular nutrient gaps, handling chronic conditions, and supporting tailored health aims such as immune function, enhanced mobility, and advanced digestion.
| Segment | Share 2025 (%) |
| Diabetes | 29% |
| Oncology | 19% |
| Gastrointestinal Disorders | 16% |
| Neurological Disorders | 11% |
| Renal Disorders | 10% |
| Critical Care | 9% |
| Malnutrition & Sarcopenia | 6% |
Diabetes Segment Led the Medical Nutrition Therapy (MNT) Market in 2025
The diabetes segment contributed the largest market share of 29 in 2025. Medical nutrition therapy (MNT) is an indispensable component of diabetes management, which comprises counseling and recommendations for dietary intake and nutrition provided by a registered dietician (RD). It involves designing diet plans customized to each patient's requirements, along with regular monitoring by the RD and diabetologist.
The oncology segment held a significant share of 19% of the market, and is expected to grow at the fastest 9.76% CAGR during the forecast period as medical nutrition therapy (MNT) in oncology optimizes patient results by combating malnutrition, managing treatment adverse effects, and enhancing quality of life. In adults with tumours, dietitian interventions have an advantageous effect on nutrition status, length of stay, quality of life, and protein and energy intake.
The gastrointestinal disorders segment held a significant share of 16% of the medical nutrition therapy (MNT) market, as MNT helps the treatment of GI disorders by promoting healthy eating habits that help digestive health and lower symptoms.
The neurological disorders segment held a significant share of 11% of the market, as a well-balanced diet significantly feeds the brain when it comes to neurological conditions. Tailored interferences supports address complexities such as swallowing difficulty, weight loss, and diet-medication connections.
| Segment | Share 2025 (%) |
| Oral | 51% |
| Enteral Tube Feeding | 34% |
| Parenteral | 15% |
Oral Segment Led the Medical Nutrition Therapy (MNT) Market in 2025
The oral segment contributed the largest market share of 51%, as oral dosage forms are usually the most convenient choice. It is the simplest, most convenient, and safest means of drug administration. It is the most favored route because of its benefits, like non-invasiveness, patient compliance, and the convenience of therapeutic administration.
The enteral tube feeding segment held a significant share of 34% in the market, as tube feeding uses a feeding tube to deliver nutrients and fluids to the body if patients can't safely chew or swallow. Tube feeding with real food ingredients may be beneficial for children and adults who have difficulty tolerating a standard formula.
The parenteral segment held a significant share of 15% in the market, and is expected to grow at the fastest 8.63% CAGR during the forecast period, as the parenteral route offers a rapid onset of action and prevents first-pass metabolism. Though they need skilled administration and are more costly than oral medicine. Parenteral drug administration offers rapid relief to patients who cannot take drugs orally or have gastrointestinal challenges.
| Segment | Share 2025 (%) |
| Powder | 38% |
| Liquid | 36% |
| Semi-Solid | 11% |
| Modular Nutrition Components | 15% |
The Powder segment led the Medical Nutrition Therapy (MNT) Market in 2025
The powder segment contributed the largest market share of 38%, as powders have better physicochemical stability and longer shelf life as compared to liquid dosage forms. Powder dosage forms are free from preservatives, allow large doses of drug administration, prevent microbial contamination, and improve patient compliance, making them noteworthy candidates for nasal delivery.
The liquid segment held a significant share of 36% in the market, and is expected to grow at the fastest 8.91% CAGR during the forecast period, as liquid dosage forms are gaining popularity at a much faster rate than solid dosage forms. Liquid dosage forms are appropriate for the administration of hydrophobic compounds.
The semi-solid segment held a significant share of 11% in the medical nutrition therapy (MNT) market, as semi-solid feeds are valuable in lowering the occurrence of abdominal distension, diarrhea, vomiting, and hospital stay. Semi-solid feeds like pectin and other substances are injected via the nasal feeding tube so that pectin and a liquid nutrient solution are mixed and enter the stomach in a semi-solidified chylous state, close to the chylous state as a result of food being ground in the stomach.
The modular nutrition components segment held a significant share of 15% in the market, as modular protein supplements are added to either the diet or enteral formula to increase the protein or amino acid intakes of populations who are nutritionally compromised. Modular protein supplements are generally offered either as a substrate for protein synthesis.
| Segment | Share 2025 (%) |
| Hospitals | 41% |
| Home Care Settings | 27% |
| Long-Term Care Facilities | 15% |
| Ambulatory Surgical Centers | 7% |
| Specialty Clinics | 10% |
The Hospitals Segment Led the Market in 2025
The hospitals segment led the medical nutrition therapy (MNT) market with 41% share in 2025 because hospitals manage critical illnesses, surgical recovery, and chronic disease complications requiring specialized nutritional support. Rising admissions for diabetes, cancer, and gastrointestinal disorders increased demand for clinically supervised nutrition plans, enteral feeding, and services.
The home care settings segment held 27% share in 2025, and is expected to grow at the fastest CAGR of 9.38% during the forecast period due to increasing preference for personalized treatment at home. Aging populations, rising chronic disease cases, and technological advancements in remote monitoring encouraged patients to adopt convenient nutritional solutions.
The long-term care facilities segment held 15% share of the medical nutrition therapy (MNT) market in 2025 because elderly and chronically ill patients require continuous nutritional management. The increasing prevalence of age-related disorders, malnutrition risks, and rehabilitation needs boosted demand for structured dietary programs, professional monitoring, and specialized nutrition support within environments.
The speciality clinics segment held 10% share in 2025 due to increasing demand for disease-specific nutritional counseling. Clinics treating diabetes, oncology, gastrointestinal disorders, and metabolic conditions integrated medical nutrition therapy into personalized treatment plans, improving patient outcomes while supporting healthcare and disease management.
In 2025, North America dominated the medical nutrition therapy (MNT) market with a share of 38% in 2025, due to the increasing incidence of chronic diseases, which are the leading cause of illness, death, and disability in the United States, affecting more than half of the population. Malnutrition in the population is caused by many factors, involving age-related changes in physiology, chronic illnesses, financial limitations, social isolation, and functional limitations, which increase the demand for medical nutrition therapy.
U.S. Market Trends
The U.S. medical care sector is a leader in scientific nutrition education for physicians and RDs, integrating nutrition screening in the quality improvement programs (QIPs). Major worldwide nutrition companies such as Abbott and Nestlé have a heavy presence in the U.S., increasing innovation in oral and enteral nutrition products.
Asia Pacific held 24% share of the medical nutrition therapy (MNT) market, expected to have the fastest growth of 9.46% CAGR during the forecast period, as growing demand for particular formulations, such as those for pediatrics, geriatrics, oncology, and malnutrition, is increasing in hospitals, long-term care facilities, and home-care settings. A recent trend is the transition towards targeted nutrition, simplified by AI-based diagnostics and telehealth platforms that customize nutritious plans for patients, which drives the growth of the market.
India Market Trends
India is undergoing a huge increase in lifestyle diseases, specifically diabetes and heart disease, needs targeted, long-term medical nutrition interventions. India utilizes traditional systems such as Ayurveda, which emphasizes diet and nutrition for preventing and managing diseases. Improved access to, and data about, medical nutrition products via e-commerce platforms is increasing accessibility.
| Ecosystem Segment | Key Participants | Role in Market |
| Technology Providers | Abbott, Nestlé Health Science, Danone Nutricia | Develop clinical nutrition formulations and nutrition technologies |
| Product Manufacturers | Fresenius Kabi, Baxter International, B. Braun | Manufacture enteral and parenteral nutrition products |
| Service Providers | Sodexo Healthcare, Nutricia Homeward, Option Care Health | Deliver nutritional support and patient care services |
| Platform Providers | Healthie, Nutrium, Cronometer Pro | Nutrition management and patient engagement platforms |
| CROs/CDMOs | Catalent, Recipharm, Fareva | Support formulation development and manufacturing of specialized nutrition products |
| Software Vendors | Healthie, Nutrium, Practice Better | Digital nutrition therapy and telehealth management software |
| Research Institutions | Mayo Clinic, Harvard T.H. Chan School of Public Health, NIH | Clinical nutrition research and evidence generation |
| End-User Industries | Hospitals, Home Healthcare, Long-Term Care Facilities, Specialty Clinics | Adoption and implementation of MNT programs |
R&D:
Manufacturing Processes:
Patient Services:
| Tier 1 | Tier 2 | Tier 3 | |
| Typical Market Influence | 68% | 22% | 10% |
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Abbott Laboratories | Abbott Park, Illinois | USA | Global leader in medical and therapeutic nutrition | Ensure, Glucerna, PediaSure, Vital nutrition products |
| Nestlé Health Science | Lausanne, Vaud | Switzerland | Largest clinical nutrition and medical foods portfolio | Peptamen, Resource, Compleat, oncology nutrition |
| Fresenius Kabi | Bad Homburg, Hesse | Germany | Major global provider of enteral and parenteral nutrition | Clinical nutrition, IV nutrition, enteral feeding |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| B. Braun SE | Melsungen, Hesse | Germany | Strong parenteral nutrition portfolio | Nutriflex, Nutricomp, IV nutrition |
| Ajinomoto Co., Inc. | Tokyo | Japan | Amino acid-based clinical nutrition products | Amino acid formulations, medical nutrition |
| Meiji Holdings Co., Ltd. | Tokyo | Japan | Significant clinical and enteral nutrition presence | Meibalance clinical nutrition products |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Kate Farms | Santa Barbara, California | USA | Fast-growing plant-based medical nutrition company | Organic enteral and oral nutrition formulas |
| Functional Formularies | Centerville, Ohio | USA | Pioneer in whole-food tube-feeding formulas | Enteral nutrition products |
| Nutricia North America Specialized Nutrition Division | Rockville, Maryland | USA | Specialized metabolic and rare disease nutrition | Metabolic nutrition therapies |
Strengths
Weakness
Opportunities
Threat
By Product Type
By Therapeutic Area
By Application
By Route of Administration
By Age Group
By Formulation
By Distribution Channel
By End User
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
